General Information of the Compound
| Compound ID |
CP0918905
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-((S)-5-cyclohexyl-2,3-dihydro-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1H-benzo[e][1,4]diazepin-3-yl)-N-(3-(methylamino)phenyl)-acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H38N4O3
|
||||||||||||||||||
| Molecular Weight |
502.659
|
||||||||||||||||||
| Canonical SMILES |
CNc1cccc(NC(=O)C[C@@H]2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H38N4O3/c1-30(2,3)26(35)19-34-25-16-9-8-15-23(25)28(20-11-6-5-7-12-20)33-24(29(34)37)18-27(36)32-22-14-10-13-21(17-22)31-4/h8-10,13-17,20,24,31H,5-7,11-12,18-19H2,1-4H3,(H,32,36)/t24-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFNSLUVCTGTZGY-DEOSSOPVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00958, Cholecystokinin receptor type A
Protein ID: PT01124, Gastrin/cholecystokinin type B receptor